Automata’s Lara Matthews interviews Will Ferguson, VP of Pharmaceutical & Biotech Collaborations at Illumina, about the evolving landscape of genomics and its transformative role in biopharma.
They discuss Illumina’s partnerships in large-scale genomic data generation projects, the impact of this data on drug discovery, and the future potential of whole genome sequencing in the clinic.
More episodes
Automated cell biology labs of the future
Automation has the potential to help achieve high-quality, repeatable results delivered quicker…
Read more Automated cell biology labs of the future
Challenges of working with genetically edited cells
Sonia Jassi, Drug Discovery and Synthetic Biology Lead at Automata, examines how gene…
Read more Challenges of working with genetically edited cells
Enabling clinicians and patients to make data-driven decisions with genomics
Nick Lench, Genomics Expert and Co-Founder of Congenica, discusses the challenges holding…
Read more Enabling clinicians and patients to make data-driven decisions with genomics